Gray Nancy Ryan 4
4 · LIGAND PHARMACEUTICALS INC · Filed Jun 7, 2021
Insider Transaction Report
Form 4
Gray Nancy Ryan
Director
Transactions
- Award
Common Stock
2021-06-04+630→ 3,702 total - Award
Non-Qualified Stock Option (right to buy)
2021-06-04+3,269→ 3,269 totalExercise: $115.39Exp: 2031-06-04→ Common Stock (3,269 underlying)
Footnotes (2)
- [F1]Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 04, 2021. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.
- [F2]Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 04, 2021. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.